IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v5y2021i2d10.1007_s41669-020-00246-3.html
   My bibliography  Save this article

Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market

Author

Listed:
  • Sreenivasa Murthy

    (LifeCare Hospital and Research Centre)

  • Pankaj Aneja

    (Max Super Speciality Hospital)

  • Arthur Joseph Asirvatham

    (Arthur Asirvatham Hospital)

  • Lise Lotte N. Husemoen

    (Novo Nordisk A/S)

  • Nicolai A. Rhee

    (Novo Nordisk Health Care AG)

  • Jothydev Kesavadev

    (Jothydev’s Diabetes Research Center)

Abstract

Objective Our objective was to investigate willingness to pay (WTP) for biphasic insulin aspart 30/70 (BIAsp 30) in patients with type 2 diabetes mellitus (T2DM) in India. Methods A multicenter, prospective, non-interventional, preference study was conducted that assessed WTP for BIAsp 30 in an insulin pen (FlexPen® or Penfill® device) in patients in India with T2DM previously treated with biphasic human insulin (BHI) in vials and believed to be able to pay for treatment. The primary endpoint was the proportion of patients willing to continue to pay for BIAsp 30 after 12 weeks’ treatment. Secondary endpoints included the change from baseline in treatment and device satisfaction and patient preferences for treatment attributes as assessed by a nested discrete-choice experiment. Results Overall, 54.9% (n = 277/505) of participants were male; the mean age was 56.4 years; diabetes duration was 10.9 years; 63.8% had a body mass index ≥ 25 kg/m2; > 75% had an annual household income > 150,000 Indian rupees (INR). After 12 weeks’ treatment, 96.4% of patients were willing to pay for BIAsp 30. Mean treatment and device satisfaction significantly improved from baseline (p

Suggested Citation

  • Sreenivasa Murthy & Pankaj Aneja & Arthur Joseph Asirvatham & Lise Lotte N. Husemoen & Nicolai A. Rhee & Jothydev Kesavadev, 2021. "Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market," PharmacoEconomics - Open, Springer, vol. 5(2), pages 261-273, June.
    • Handle: RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00246-3
    DOI: 10.1007/s41669-020-00246-3
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-020-00246-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-020-00246-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Blog mentions

    As found by EconAcademics.org, the blog aggregator for Economics research:
    1. Journal round-up: PharmacoEconomics – Open 5(2)
      by Rita Faria in The Academic Health Economists' Blog on 2021-07-26 06:00:01

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00246-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.